
The UK medicine regulatory authority has suspended the licence for a levothyroxine product sold by Teva on the grounds that …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations

